Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marit Ahrens

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Urologie (Heidelberg, Germany)|November 26, 2024
[Non-clear cell renal cell carcinoma]Marit Ahrens, Lothar Bergmann
Deutsche Medizinische Wochenschrift (1946)|June 4, 2020
[What is new in the diagnosis and therapy of renal cell carcinoma?]Marit Ahrens, Arndt Hartmann, Lothar Bergmann
Expert Review of Anticancer Therapy|July 22, 2021
Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overviewLothar Bergmann, Sarah Weber, Arndt Hartmann, et al.
Oncology Research and Treatment|February 26, 2019
Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment OptionsMarit Ahrens, Sebastian Scheich, Arndt Hartmann, et al.
Sarcoma|April 26, 2018
Limb-Salvage Surgery of Soft Tissue Sarcoma with Sciatic Nerve InvolvementHussein Sweiti, Noor Tamimi, Fabian Bormann, et al.
International Journal of Oncology|May 9, 2013
Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and ageMathias Hoiczyk, Florian Grabellus, Lars Podleska, et al.
American Journal of Respiratory Cell and Molecular Biology|June 7, 2003
Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungsNorbert Weissmann, Nadine Ebert, Marit Ahrens, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
The Prostate|July 11, 2024
Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancerMike Wenzel, Nele Wagner, Benedikt Hoeh, et al.
Deutsches Arzteblatt International|June 24, 2025
Radical Prostatectomy Versus Radiotherapy for Prostate Cancer: Stage-, Age-, and Frailty-Specific Cancer-Control Outcomes of 2600 PatientsMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Urologie (Heidelberg, Germany)|November 26, 2024
[Non-clear cell renal cell carcinoma]Marit Ahrens, Lothar Bergmann
Deutsche Medizinische Wochenschrift (1946)|June 4, 2020
[What is new in the diagnosis and therapy of renal cell carcinoma?]Marit Ahrens, Arndt Hartmann, Lothar Bergmann
Expert Review of Anticancer Therapy|July 22, 2021
Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overviewLothar Bergmann, Sarah Weber, Arndt Hartmann, et al.
Oncology Research and Treatment|February 26, 2019
Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment OptionsMarit Ahrens, Sebastian Scheich, Arndt Hartmann, et al.
Sarcoma|April 26, 2018
Limb-Salvage Surgery of Soft Tissue Sarcoma with Sciatic Nerve InvolvementHussein Sweiti, Noor Tamimi, Fabian Bormann, et al.
International Journal of Oncology|May 9, 2013
Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and ageMathias Hoiczyk, Florian Grabellus, Lars Podleska, et al.
American Journal of Respiratory Cell and Molecular Biology|June 7, 2003
Effects of mitochondrial inhibitors and uncouplers on hypoxic vasoconstriction in rabbit lungsNorbert Weissmann, Nadine Ebert, Marit Ahrens, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
The Prostate|July 11, 2024
Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancerMike Wenzel, Nele Wagner, Benedikt Hoeh, et al.
Deutsches Arzteblatt International|June 24, 2025
Radical Prostatectomy Versus Radiotherapy for Prostate Cancer: Stage-, Age-, and Frailty-Specific Cancer-Control Outcomes of 2600 PatientsMike Wenzel, Katrin Burdenski, Nikolaos Tselis, et al.
Pageof 3